MedPath

Can Ultrasound Replace Amniocentesis for Confirming Fetal Lung Maturation Among Premature Fetuses?

Not Applicable
Terminated
Conditions
Fetal Lung Maturity
Interventions
Device: Ultrasound
Registration Number
NCT00720252
Lead Sponsor
HaEmek Medical Center, Israel
Brief Summary

The purpose of this study is to measure prenatally with ultrasound the intratracheal flow volume displaced during breathing cycle in premature fetuses and to check whether a relationship exists between the inspired fluid and fetal lung maturation.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
10
Inclusion Criteria
  • Women delivering between 27 to 37 weeks.
  • Women undergoing amniocentesis for determining fetal lung maturity between 27 to 37 weeks.
Exclusion Criteria
  • Major fetal malformation.
  • Oligohydramnios or rupture of membranes diagnosed before 24 weeks of gestation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
AUltrasound-
Primary Outcome Measures
NameTimeMethod
To check whether a threshold exists between peak velocity and/or volume of fluid inspired by the fetus and lung maturation.end of the study
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Dep. OB/GYN, HaEmek Medical Center

🇮🇱

Afula, Israel

© Copyright 2025. All Rights Reserved by MedPath